Oscar Health Statistics
Total Valuation
Oscar Health has a market cap or net worth of $9.67 billion. The enterprise value is $6.07 billion.
| Market Cap | 9.67B |
| Enterprise Value | 6.07B |
Important Dates
The next confirmed earnings date is Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Oscar Health has 308.33 million shares outstanding. The number of shares has increased by 17.37% in one year.
| Current Share Class | 273.15M |
| Shares Outstanding | 308.33M |
| Shares Change (YoY) | +17.37% |
| Shares Change (QoQ) | +1.12% |
| Owned by Insiders (%) | 3.85% |
| Owned by Institutions (%) | 62.37% |
| Float | 263.61M |
Valuation Ratios
The trailing PE ratio is 16.43 and the forward PE ratio is 17.20.
| PE Ratio | 16.43 |
| Forward PE | 17.20 |
| PS Ratio | 0.63 |
| Forward PS | 0.49 |
| PB Ratio | 4.71 |
| P/TBV Ratio | 4.71 |
| P/FCF Ratio | 2.21 |
| P/OCF Ratio | 2.19 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.23, with an EV/FCF ratio of 1.39.
| EV / Earnings | 11.03 |
| EV / Sales | 0.40 |
| EV / EBITDA | 9.23 |
| EV / EBIT | 9.64 |
| EV / FCF | 1.39 |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.08 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 0.72 |
| Debt / FCF | 0.11 |
| Interest Coverage | 39.73 |
Financial Efficiency
Return on equity (ROE) is 34.26% and return on invested capital (ROIC) is 25.10%.
| Return on Equity (ROE) | 34.26% |
| Return on Assets (ROA) | 4.47% |
| Return on Invested Capital (ROIC) | 25.10% |
| Return on Capital Employed (ROCE) | 24.82% |
| Weighted Average Cost of Capital (WACC) | 17.13% |
| Revenue Per Employee | $6.65M |
| Profits Per Employee | $238,934 |
| Employee Count | 2,305 |
| Asset Turnover | 1.74 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Oscar Health has paid $38.88 million in taxes.
| Income Tax | 38.88M |
| Effective Tax Rate | 6.59% |
Stock Price Statistics
The stock price has increased by +62.52% in the last 52 weeks. The beta is 2.47, so Oscar Health's price volatility has been higher than the market average.
| Beta (5Y) | 2.47 |
| 52-Week Price Change | +62.52% |
| 50-Day Moving Average | 31.78 |
| 200-Day Moving Average | 23.40 |
| Relative Strength Index (RSI) | 45.60 |
| Average Volume (20 Days) | 4,694,078 |
Short Selling Information
The latest short interest is 16.45 million, so 5.34% of the outstanding shares have been sold short.
| Short Interest | 16.45M |
| Short Previous Month | 16.36M |
| Short % of Shares Out | 5.34% |
| Short % of Float | 6.24% |
| Short Ratio (days to cover) | 3.02 |
Income Statement
In the last 12 months, Oscar Health had revenue of $15.32 billion and earned $550.74 million in profits. Earnings per share was $1.91.
| Revenue | 15.32B |
| Gross Profit | 3.09B |
| Operating Income | 629.72M |
| Pretax Income | 589.81M |
| Net Income | 550.74M |
| EBITDA | 657.96M |
| EBIT | 629.72M |
| Earnings Per Share (EPS) | $1.91 |
Balance Sheet
The company has $8.56 billion in cash and $482.10 million in debt, with a net cash position of $3.59 billion or $11.65 per share.
| Cash & Cash Equivalents | 8.56B |
| Total Debt | 482.10M |
| Net Cash | 3.59B |
| Net Cash Per Share | $11.65 |
| Equity (Book Value) | 2.06B |
| Book Value Per Share | 6.66 |
| Working Capital | 683.68M |
Cash Flow
In the last 12 months, operating cash flow was $4.42 billion and capital expenditures -$38.63 million, giving a free cash flow of $4.38 billion.
| Operating Cash Flow | 4.42B |
| Capital Expenditures | -38.63M |
| Depreciation & Amortization | n/a |
| Net Borrowing | 371.12M |
| Free Cash Flow | 4.38B |
| FCF Per Share | $14.21 |
Margins
Gross margin is 20.16%, with operating and profit margins of 4.11% and 3.60%.
| Gross Margin | 20.16% |
| Operating Margin | 4.11% |
| Pretax Margin | 3.85% |
| Profit Margin | 3.60% |
| EBITDA Margin | 4.30% |
| EBIT Margin | 4.11% |
| FCF Margin | 28.59% |
Dividends & Yields
Oscar Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -17.37% |
| Shareholder Yield | -17.37% |
| Earnings Yield | 6.09% |
| FCF Yield | 45.31% |
Analyst Forecast
The average price target for Oscar Health is $36.40, which is 16.11% higher than the current price. The consensus rating is "Hold".
| Price Target | $36.40 |
| Price Target Difference | 16.11% |
| Analyst Consensus | Hold |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 27.77% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |